Miotine
Miotine is an anticholinesterase drug. Miotine was the first synthetic carbamate that was used clinically.[1]
Names | |
---|---|
IUPAC name
[3-[1-(Dimethylamino)ethyl]phenyl] N-methylcarbamate | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
KEGG | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C12H18N2O2 |
Molar mass | 222.288 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
Unlike the miotine analog neostigmine, it doesn't have a quaternary ammonium group to give it a permanent positive charge. It can exist as an uncharged free base which could allow it to cross the blood–brain barrier and cause unwanted central nervous system (CNS) side effects.[2]
See also
- Neostigmine
- T-1123
- TL-1238
- TMTFA
References
- "Archived copy" (PDF). Archived from the original (PDF) on 2009-05-09. Retrieved 2008-01-04.
{{cite web}}
: CS1 maint: archived copy as title (link) - "An introduction to drugs,their action and discovery" (PDF).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.